Abstract:Esophageal carcinoma (ESCA) is a common and lethal malignant tumor worldwide. The mitochondrial biomarkers were useful in finding significant prognostic gene modules associated with ESCA owing to the role of mitochondria in tumorigenesis and progression. In the present work, we obtained the transcriptome expression profiles and corresponding clinical information of ESCA from The Cancer Genome Atlas (TCGA) database. Differential expressed genes (DEGs) were overlapped with 2030 mitochondria-related genes to get mitochondria-related DEGs. The univariate cox regression, Least Absolute Shrinkage and Selection Operator (LASSO) regression, and multivariate cox regression were sequentially used to define the risk scoring model for mitochondria-related DEGs, and its prognostic value was verified in the external datasets GSE53624. Based on the risk score, ESCA patients were divided into high- and low-risk groups. Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), and Gene Set Enrichment Analysis (GSEA) were performed to further investigate the difference between low- and high-risk groups at the gene pathway level. CIBERSORT was used to evaluate immune cell infiltration. The mutation difference between high- and low-risk groups was compared by using the R package "Maftools". Cellminer was used to assess the association between the risk scoring model and drug sensitivity. As the most important outcome of the study, a 6-gene risk scoring model (APOOL, HIGD1A, MAOB, BCAP31, SLC44A2, and CHPT1) was constructed from 306 mitochondria-related DEGs. Pathways including the "hippo signaling pathway" and "cell-cell junction" were enriched in the DEGs between high and low groups. According to CIBERSORT, samples with high-risk scores demonstrated a higher abundance of CD4+ T cells, NK cells, M0 and M2 macrophages, and a lower abundance of M1 macrophages. The immune cell marker genes were correlated with the risk score. In mutation analysis, the mutation rate of TP53 was significantly different between the high- and low-risk groups. Drugs with a strong correlation with the risk model were selected. In conclusion, we focused on the role of mitochondria-related genes in cancer development and proposed a prognostic signature for individualized integrative assessment.

Mitochondrial DNA somatic mutations and germline variations in patients with esophageal cancer

Somatic Mutation Detection in Complete Mitochondrial DNA of Lung Cancer Patients

The somatic mutations of mitochondrial genome in Chinese patients with breast cancer

Frequent Mtdna Mutations and Its Role in Gastric Carcinogenesis

Uncovering the Profile of Somatic Mtdna Mutations in Chinese Colorectal Cancer Patients

Detection of Mosaic Pattern of Mitochondrial DNA Alterations in Different Populations of Cells from the Same Endometrial Tumor.

Influence of instability of mitochondrial genome length on tumorigenesis in human tumors

A Comprehensive Characterization of Mitochondrial Genome in Papillary Thyroid Cancer

Somatic Mutations Of Mitochondrial Genome In Early Stage Breast Cancer

Deciphering the Signature of Selective Constraints on Cancerous Mitochondrial Genome

Mitochondrial DNA in Lung Cancer

Investigation of Frequent Somatic Mutations of MTND5 Gene in Gastric Cancer Cell Lines and Tissues

Variations of Mitochondrial D-loop Region Plus Downstream Gene 1 2S Rrna-Trna^phe and Gastric Carcinomas

Leveraging new methods for comprehensive characterization of mitochondrial DNA in esophageal squamous cell carcinoma

Mitochondrial DNA Mutation of Peripheral White Blood Cells in Lung Cancer

Identification of the Germline Mutation Profile in Esophageal Squamous Cell Carcinoma by Whole Exome Sequencing

A novel mitochondria-related gene signature in esophageal carcinoma: prognostic, immune, and therapeutic features

Analysis of Mitochondrial DNA Microsatellite Instability in Esophageal Squamous Cell Carcinoma

[Somatic Mutations of Mitochondrial DNA in Thyroid Papillary Carcinoma].

Mutations of Mitochondrial DNA As Potential Biomarkers in Breast Cancer.

Germline and Somatic Variations Influence the Somatic Mutational Signatures of Esophageal Squamous Cell Carcinomas in a Chinese Population